Key result
Standard heart failure therapy restores LVEF to 48% in a mitochondrial A3243G dilated cardiomyopathy case.
Why the study?
The clinical presentation and progression of acute dilated cardiomyopathy associated with the mitochondrial A3243G mutation require detailed characterization.
Case Report (n=1)
Standard heart failure therapy can lead to significant clinical and echocardiographic improvement in patients with acute dilated cardiomyopathy associated with the mitochondrial A3243G mutation.
May support reversibility of mitochondrial cardiomyopathy with standard therapy; leaves open generalizability beyond this single case.
A 35-year-old woman (body mass index, 16 kg/m 2 ; height, 140 cm) presented to the emergency ward with severe dyspnea of acute onset.The medical history was noteworthy for bilateral hypacusis treated with a hearing aid.On admission, the laboratory results revealed an N-terminal prohormone of brain natriuretic peptide level of 10 219 ng/L (normal Ͻ200 ng/L).Thoracic CT scan excluded pulmonary embolism but showed cardiomegaly with pericardial and bilateral pleural effusion suggesting the presence of acute heart failure.Cardiac MRI (CMR) demonstrated a severely reduced left ventricular ejection fraction (LVEF, 13%) and severe right ventricular dysfunction (Figure 1A and 1B, baseline); LV mass index was normal.Late gadolinium enhancement images demonstrated extensive subepicardial lesions in inferior and lateral LV segments (Figure 1C, baseline).The angiogram excluded a coronary pathology, and myocardial histology was without histological signs of infiltrative or active inflammatory disease.The ECG was noteworthy for a shortened PQ interval, but supraventricular tachycardia was not revealed during long-term ECG monitoring.Otherwise, the patient showed a hyperglycemic fasting glucose level (7.5 mmol/L; normal Ͻ5.6 mmol/L), and, whereas lactate level was normal at rest (2 mmol/L; normal Ͻ2.4 mmol/L), a rapid increase to 4.3 mmol/L was noteworthy after 150 seconds of bicycle exercise at 35 W. Cerebral MRI showed cerebellar atrophy (Figure 2) in the absence of a clinically relevant neurological disorder, and ophthalmologic examination revealed bilateral ocular maculopathy.With standard heart failure therapy including low-dose -blockade, angiotensin-converting enzyme inhibition, aldosterone blockade, and loop diuretics, the patient recovered to New York Heart Association class II; in parallel, the NT-proBNP-level decreased to 391 ng/L.After 18 months, CMR showed significant improvement of systolic biventricular function (LVEF, 48%; minor right ventricular dysfunction) (Figure 1D and 1E), whereas volume and pattern of the myocardial lesions remained unchanged (Figure 1F).
No takes yet. Share an insight, caveat, or question.
Stalder et al. (2012) conducted a case report in Acute dilated cardiomyopathy associated with mitochondrial A3243G mutation (n=1). Standard heart failure therapy was evaluated on Clinical recovery and left ventricular ejection fraction (LVEF) improvement. Standard heart failure therapy in a 35-year-old woman with acute dilated cardiomyopathy and mitochondrial A3243G mutation improved LVEF from 13% to 48% over 18 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: